NCT06301126

Brief Summary

After upper abdomen surgery, respiratory muscle dysfunction is well recognised. After laparotomy and even laparoscopy, maximum static inspiratory and expiratory pressures are lowered, and recovery can take several days. A variety of reasons have been implicated in such respiratory muscle dysfunction, including irritation and inflammation, as well as injuries near the diaphragm, resulting in local mechanical failure, reflex inhibition, and pain.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 8, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2024

Enrollment Period

1.3 years

First QC Date

February 26, 2024

Last Update Submit

May 10, 2025

Conditions

Keywords

Virtual realityPulmonary FunctionRespiratory Muscle StrengthFunctional CapacityUpper abdominal surgery

Outcome Measures

Primary Outcomes (1)

  • Forced vital capacity (FVC)

    FVC will be measured by using spirometer.

    8 weeks

Secondary Outcomes (5)

  • Forced expiratory volume in 1 second (FEV1)

    8 weeks

  • Peak expiratory flow (PEF)

    8 weeks

  • Respiratory muscle strength

    8 weeks

  • diaphragmatic mobility

    8 weeks

  • Functional capacity

    8 weeks

Study Arms (2)

Virtual reality

EXPERIMENTAL

Participants will receive VR for 20 minutes followed by conventional physical therapy program for 45 minutes, 5 days/ week for 8 weeks.

Other: Virtual realityOther: conventional physical therapy exercise program

Control

ACTIVE COMPARATOR

Participants will receive conventional physical therapy program (Deep diaphragmatic, costal breathing exercises, bronchial hygiene techniques and assisted cough) for 45 minutes, 5 days/ week for 8 weeks.

Other: conventional physical therapy exercise program

Interventions

The system included an Xbox 360® console, a sensor that detects motion (Kinect®), and a projector device with loudspeakers. The console, which was mounted on a table, reached 1 m tall. The Kinect® motion sensor was attached to the projector, which showed images onto a wall 2.5 metres distant from the playing field. The playing field was at least 1.8 m wide and 1.8 m long, with the Kinect® sensor situated 1.2 m away. The device was calibrated before each training session to accurately follow the motions of each subject.

Virtual reality

Participants will receive conventional physical therapy exercise program (Deep diaphragmatic, costal breathing exercises, bronchial hygiene techniques and assisted cough) for 45 minutes, 5 days/ week for 8 weeks.

ControlVirtual reality

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients undergone open upper abdominal surgery (hernia repair, cholecystectomy, large bowel removal, conventional laparotomy)
  • no prior surgical intervention for esophageal, gastric, or biliary tract resection
  • age 18-60 years
  • acceptable physical condition (permitting pulmonary function and functional capacity test).

You may not qualify if:

  • Cerebrovascular disease
  • use of immunosuppressants within 30 days of surgery
  • cardiovascular instability
  • chest physical therapy within the 8 weeks preceding study enrollment
  • visual impairment or hearing impairment;
  • bed-ridden patients;
  • any lung disorders
  • insulin-dependent diabetes mellitus
  • less than 6-months post thoracic or cardiac surgery
  • musculoskeletal impairment
  • cognitive disorders
  • Patients undergoing laparoscopic surgery as this induces smaller changes in the postoperative breathing mechanics than laparotomy does
  • heavy smokers or alcoholism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy

Giza, 12111, Egypt

Location

MeSH Terms

Conditions

Hernia, Abdominal

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Hadaya M Eladl, PhD

    Assistant professor of physical therapy for surgery, Faculty of physical therapy

    STUDY CHAIR
  • Nabil M Abdel-Aal, PhD

    Assistant professor of physical therapy for basic sciences, Faculty of physical therapy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of physical therapy for surgery, Faculty of physical therapy

Study Record Dates

First Submitted

February 26, 2024

First Posted

March 8, 2024

Study Start

March 1, 2024

Primary Completion

June 1, 2025

Study Completion

July 1, 2025

Last Updated

May 14, 2025

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Study results

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
6 months after publication
Access Criteria
Study protocol

Locations